Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis
- PMID: 2176091
- DOI: 10.1111/j.1365-2133.1990.tb04189.x
Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis
Abstract
To determine whether the clinical, immunological and serological features of patients with silica-associated systemic sclerosis are different from patients with the 'idiopathic' form of systemic sclerosis (SS) we studied 22 underground coal miners who were exposed to silica dust (SD), 30 mine workers who later developed silicosis (S) and 17 mine workers exposed to silica dust who subsequently developed a systemic sclerosis-like disease (SA-SS). The patients with SA-SS had features clinically indistinguishable from individual patients with SS. They all had Raynaud's phenomenon, 14 had cutaneous sclerosis identical to that seen in acrosclerosis and three had a generalized cutaneous sclerosis. Sixteen patients had bibasilar pulmonary fibrosis, 10 had necrosis of the fingertip pulps, nine had oesophageal involvement and only one patient had renal involvement. Antinuclear antibodies and circulating immune complexes were detected in three and eight patients with SD, 14 and five patients with S and in 16 and nine patients with SA-SS, respectively. Anti-Scl-70 antibody was detected in eight of the 17 patients with SA-SS. Evidence for in vivo endothelial cell damage, as determined by elevated levels of von Willebrand factor, was found in nine patients with SD, 14 patients with S and in 10 patients with SA-SS. Following incubation of the patient's serum with confluent cultures of human umbilical vein endothelial cells there was only a significant reduction in calcium ionophore-induced release of prostacyclin with the serum from SA-SS patients compared to that with control serum (NC). The mean +/- SEM release of 6-keto-PGF1 alpha (the stable metabolite of prostacyclin expressed as ng/10(4) cells) decreased from 2.90 +/- 0.27 to 2.01 +/- 0.33 (SD), 3.34 +/- 0.42 to 1.76 +/- 0.31 (S), 1.98 +/- 0.12 to 0.64 +/- 0.07 (SA-SS) and 2.28 +/- 0.33 to 1.36 +/- 0.21 (NC) with 1 and 20% serum, respectively. This study demonstrates that immune complex and antinuclear antibody formation and in vivo endothelial cell damage occurs following occupational exposure to silica. The patients who subsequently develop a systemic sclerosis-like disease have clinical, immunological and serological features which are indistinguishable from the idiopathic form of the disease although as a group the SA-SS patients have a higher prevalence of pulmonary involvement and the anti-Scl-70 antibody.
Similar articles
-
[Silica-induced scleroderma in miners in former uranium ore mining (Wismut AG)].Hautarzt. 2021 Jul;72(7):644-646. doi: 10.1007/s00105-021-04791-8. Epub 2021 Mar 15. Hautarzt. 2021. PMID: 33721048 German.
-
[Silica-associated systemic sclerosis occurring after an occupational exposure to arc welding].Pan Afr Med J. 2016 Oct 4;25:70. doi: 10.11604/pamj.2016.25.70.10390. eCollection 2016. Pan Afr Med J. 2016. PMID: 28292033 Free PMC article. French.
-
Male systemic sclerosis and occupational silica exposure-a population-based study.Aust N Z J Med. 2000 Apr;30(2):215-20. doi: 10.1111/j.1445-5994.2000.tb00810.x. Aust N Z J Med. 2000. PMID: 10833113
-
Lung disease caused by exposure to coal mine and silica dust.Semin Respir Crit Care Med. 2008 Dec;29(6):651-61. doi: 10.1055/s-0028-1101275. Epub 2009 Feb 16. Semin Respir Crit Care Med. 2008. PMID: 19221963 Review.
-
[Male-type scleroderma: the role of occupational exposure].Schweiz Med Wochenschr. 1992 Nov 14;122(46):1746-52. Schweiz Med Wochenschr. 1992. PMID: 1333094 Review. French.
Cited by
-
Erasmus syndrome with pulmonary tuberculosis.BMJ Case Rep. 2013 Jul 8;2013:bcr2013010443. doi: 10.1136/bcr-2013-010443. BMJ Case Rep. 2013. PMID: 23839614 Free PMC article. No abstract available.
-
Erasmus Syndrome: A Case Report of Silicosis-induced Scleroderma in a 26-year-old Male.Oman Med J. 2013 Sep;28(5):e058. doi: 10.5001/omj.2013.110. Oman Med J. 2013. PMID: 31440360 Free PMC article.
-
The pathogenesis of systemic sclerosis revisited.Clin Rev Allergy Immunol. 2011 Apr;40(2):92-103. doi: 10.1007/s12016-009-8193-3. Clin Rev Allergy Immunol. 2011. PMID: 20087791 Review.
-
Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomography.BMC Pulm Med. 2022 Jan 25;22(1):44. doi: 10.1186/s12890-022-01837-y. BMC Pulm Med. 2022. PMID: 35078448 Free PMC article.
-
Innate immunity and inflammation in systemic sclerosis.Curr Opin Rheumatol. 2009 Nov;21(6):617-22. doi: 10.1097/BOR.0b013e32832fd69e. Curr Opin Rheumatol. 2009. PMID: 19633559 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous